Copper Peptide is formed as a result of the affinity of the human peptide, GHK (glycyl-L-histidyl-L-lysine), to the Cu(2+) (Copper 2+). In the human body, the Copper Peptide has varied roles like collagen stimulation, anti-inflammatory, anti-oxidant effects, enhancing the activation of wound healing, and many more. In addition, the GHK-Cu has also been reported to improve hair growth.
Hair loss regulator, DHT, is influentially inhibited by Copper Peptide.
Copper Peptide reduces the formation of DHT in the hair follicles. There are mainly two forms in which the 5-alpha reductase exists: Type 1, which plays a role in the hair follicles, and Type 2 plays a role in the prostate tissue. Throughout the body, 5-alpha Reductase is inhibited by the pro-pecia (Finasteride), thereby improving hair growth. Although the pro-pecia is more significant for the Type 2 forms, it controls the prostate’s enlargement. The administration is preferred by pills so that the substance spreads to the entire body. However, in context to the Type 1 5-AR, they are better inhibited by the increasing copper ions in the skin, thereby controlling the damage to the hair growth. As per the research conducted by the different researchers, it can be said that copper ions in the concentration of 0.12 micrograms/ml can inhibit the Type 1 5-AR by up to 90%. It is also reported that copper ions inhibit the Type 2 form less efficiently. Hence, in comparison to Finasteride, the 5-AR is more specifically inhibited by the copper ions.
The Macrophages, Inflammatory Mast Cells are activated by the Copper Peptide, and Inflammation is reduced via Antioxidation.
A plethora of remodeling-related processes are activated by these two molecules. The processes include:
(1) Repair cells’ chemo attraction like mast cells, macrophages, and capillary cells;
(2) The anti-inflammatory actions like Thromboxane formation; Vessel vasodilation; Suppression of the free radicals; Oxidizing iron release; Increase in the Superoxide dismutase, and the transformation of the growth factor beta-1, alpha-tumor necrosis factor, and protein glycation; vasodilation of vessels; protecting skin keratinocytes from ultraviolet damage; improvement of the fibroblast recovery post-X-ray treatments;
(3) Enhanced proliferation of keratinocytes and fibroblasts, angiogenesis, nerve outgrowth, and the size of the hair follicle;
(4) Enhanced synthesis of the protein collagen, anti-proteases, elastin, metalloproteinases, fibroblast growth factor, neurotrophins and erythropoietin, nerve growth factor, and vascular endothelial growth factor.
The iron toxicity is reduced by Copper Peptide
After significant ingestion, the levels of iron rise, thereby saturating the Transferrin. The excessive iron will circulate as free iron in the blood and will be toxic directly for the target organs. The Ferritin will release the GHK-Cu (2+) reduced to iron by 87%. Approximately 4500 atoms of iron per protein molecule can be stored in Ferritin, a well-recognized catalyst of lipid peroxidation, thereby producing a slew of free radicals, resulting in cell membrane damage, protein, and DNA.
Potent neurotoxin – Free iron
The entry of free iron in the cells and its accumulation in the mitochondria will disrupt the process of oxidative phosphorylation, will catalyze the lipid peroxidation forming free radicals, and hence, causes cell death.
Cell proliferation and wound healing is triggered by Copper Peptide
Research by different scientists has shown that the miR-399-5p expression is downregulated by GHK. In the cells, the anti-apoptotic effect of GHK is partially reversed due to the overexpression of miR-399-5p. The research also suggests that the downregulation of miR-339-5p induced by GHK involves the p38 MAPK pathways. The miR-399-5p/ VEGFA has also shown a role in the prevention of neuronal apoptosis as a consequence of the ICH injury.
In the cells, the miR-399-5p expression is downregulated by GHK; the miR-399-5p is overexpressed, which reverses the anti-apoptotic effects of GHK.
The anti-inflammatory actions of Copper Peptide
The GHK is found in an individual’s urine, saliva, and plasma. It is also utilized for skin care and wound treatment. It occurs naturally, is non-toxic, forms complexes with copper, readily improves the bioavailability, and regulates the metabolism of the copper. The copper (II) chelation and the GHK tripeptide together form the Copper Peptide, which accelerates the process of wound healing, regeneration, anti-inflammatory actions, and anti-oxidant actions.
The level of the TNF-α and TGF-β, the acute phase inflammatory cytokines, is lowered, thereby resulting in oxidative damage and hence, the suppression of inflammation.
Research has shown that the Copper Peptide treatment increased the superoxide dismutase and decreased the production of the reactive oxygen species. Also, the production of IL-6 and TNF-α was decreased as a result of the suppression of the p39 MAPK and NF-κB p65 in-vivo and in-vitro models.
The results of the studies have shown that the LPS-induced phosphorylation of NF- κB p65 is also inhibited by the Copper Peptide. Many studies have also reported that the Copper Peptide can inhibit the NF-κB pathway in inflammatory bowel diseases and chronic inflammatory diseases.
With all these points, it can be concluded that the Copper Peptide has the potential to improve the growth of the hair follicle. It reduces the negative effects like inflammation, iron toxicity and promotes the processes like wound healing and cell proliferation.
Disclaimer: The products mentioned are not for human or animal consumption. All the information shared in this article is for educational purposes only.